Cost-effectiveness of human papillomavirus (HPV) vaccination in Tunisia: a modelling study

Cost-effectiveness of human papillomavirus (HPV) vaccination in Tunisia: a modelling study

Objectives The objective of this study is to assess the cost utility of the implementation of the human papillomavirus (HPV) vaccination programme in Tunisia in addition to the current cytology screening strategy. This study is very important to guide health policy decision-makers and to help them a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mohamed Hsairi, Olfa Jaidane, Khedija Meddeb, Hyem Khiari, Karima Makni
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-12-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/14/12/e085462.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

HPV DNA screening and vaccination strategies in Tunisia
by: Anas Lahdhiri, et al.
Published: (2025-07-01)

Medical students’ knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer
by: Norangelys Solis-Torres, et al.
Published: (2024-12-01)

Knowledge of human papillomavirus (HPV) infection and human papillomavirus vaccine among undergraduate students at a Nigerian university
by: Aisha Funmilayo Lawal, et al.
Published: (2025-05-01)

RESULTS OF THE IMPLEMENTATION OF THE HPV (HUMAN PAPILLOMAVIRUS) VACCINATION PROGRAM IN THE MOSCOW REGION
by: article editorial
Published: (2017-08-01)

Assessing Saudi women’s awareness about human papillomavirus (HPV) and their susceptibility to receive the vaccine
by: Sana S. Alqarni, et al.
Published: (2024-12-01)

Human Papillomavirus (HPV) Vaccination: Progress, Challenges, and Future Directions in Global Immunization Strategies
by: Francesco Branda, et al.
Published: (2024-11-01)

Mathematical Model of Human Papillomavirus (HPV) Dynamics With Double-Dose Vaccination and Its Impact on Cervical Cancer
by: Henok Desalegn Desta, et al.
Published: (2024-01-01)

Cost-effectiveness of quadrivalent human papillomavirus vaccination in adolescent girls
by: A. V. Rudakova, et al.
Published: (2016-11-01)

Effect of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: A systematic review and meta-analysis.
by: Qinxue Cao, et al.
Published: (2024-01-01)

Prevalence of Human Papillomavirus (HPV) and HPV Vaccination Completion Rates Among Gay and Bisexual Men in Dar es Salaam, Tanzania
by: Lucy R. Mgopa, et al.
Published: (2024-12-01)

Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling study
by: Kaja Abbas, et al.
Published: (2021-11-01)

hpvPDB: An Online Proteome Reserve for Human Papillomavirus
by: Satish Kumar, et al.
Published: (2013-12-01)

Cost‐Effectiveness of Human Papillomavirus Vaccination for Adolescent Girls in Moscow, Russia
by: Daria A. Nefedova, et al.
Published: (2025-06-01)

Perception and knowledge of human papillomavirus (HPV) vaccine for cervical cancer prevention among fully vaccinated female university students in the era of HPV vaccination: a cross-sectional study
by: Mohamad Nasir Shafiee, et al.
Published: (2021-12-01)

Acceptability of human papillomavirus vaccination in the United Kingdom: a systematic review of the literature on uptake of, and barriers and facilitators to HPV vaccination
by: Anna Karakusevic, et al.
Published: (2024-12-01)

Human papillomavirus (HPV) vaccine clinical trials: A cross-sectional analysis of clinical trials registries
by: Edison Johannes Mavundza, et al.
Published: (2025-12-01)

Human papillomavirus (HPV) vaccination in a privately funded program in Ghana: A qualitative case study
by: Emmanuel Marfo, et al.
Published: (2024-12-01)

Cost-effectiveness modeling for gender-neutral human papillomavirus vaccines: A systematic literature review
by: Marisa Felsher, et al.
Published: (2025-12-01)

Human papillomavirus vaccine
by: Jacqui Souter
Published: (2013-10-01)

Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica.
by: Rolando Herrero, et al.
Published: (2013-01-01)

Cost-Effectiveness of Quadrivalent Human Papillomavirus Vaccination in Adolescent Girls in Russian Federation
by: Alla V. Rudakova, et al.
Published: (2018-01-01)

Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV
by: Simona Di Mario, et al.
Published: (2015-01-01)

High burden of human papillomavirus infection among men in Guangzhou, South China: Implications for HPV vaccination strategies
by: Pan Liu, et al.
Published: (2024-12-01)

Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67.
by: Zigui Chen, et al.
Published: (2011-01-01)

A male-female mathematical model of human papillomavirus (HPV) in African American population
by: Najat Ziyadi
Published: (2016-12-01)

Mathematical Models of Human Papillomavirus Transmission with Vaccination
by: Maria Lobo, et al.
Published: (2024-05-01)

Human papillomavirus (HPV) genotype distribution in Malaysia: A systematic review
by: Cassandra Sheau Mei Chee, et al.
Published: (2025-08-01)

A review of the carcinogenic potential of human papillomavirus (HPV) in urological cancers
by: Ehsan Zolfi, et al.
Published: (2025-02-01)

Corrigendum to “Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV”
by: Simona Di Mario, et al.
Published: (2017-01-01)

The effects of human papillomavirus vaccination in Japan
by: Wongyeong Choi, et al.
Published: (2025-12-01)

Estimation of the girls cost vaccination against human papillomavirus in the Siberian Federal District
by: O. A. Ananina, et al.
Published: (2024-11-01)

A participatory method to develop human papillomavirus (HPV) vaccine short video content for rural New York parents
by: Kristin Pullyblank, et al.
Published: (2024-12-01)

National Burden of Cancers in Tunisia: A Disability Adjusted Life-year Approach
by: Houda Ben Ayed, et al.
Published: (2020-09-01)

Cost-effectiveness of gender neutral vaccination of adolescents against human papillomavirus infection in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2024-01-01)

Comparison of Urine and Genital Samples for Detecting Human Papillomavirus (HPV) in Clinical Patients
by: Hui Yang, et al.
Published: (2023-01-01)

Natural history of cutaneous human papillomavirus (HPV) infection in men: the HIM study.
by: Shalaka S Hampras, et al.
Published: (2014-01-01)

Young adult perspectives on deciding to get human papillomavirus (HPV) vaccination in urban and rural communities: A qualitative research study
by: Maria E. Sundaram, et al.
Published: (2025-12-01)

Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27–45 years
by: Natalie L. Rincon, et al.
Published: (2024-12-01)

Barriers associated with the parental acceptance of human papillomavirus (HPV) vaccination of minors in Asir, Saudi Arabia: A cross-sectional study
by: Mubarak Nasser Alshahrani, et al.
Published: (2025-12-01)

Effects of different-valent vaccines against human papillomavirus (HPV) to prevent persistent HPV16/18 infections and CIN2+ in women: a systematic review and network meta-analysis
by: Haiyue Wu, et al.
Published: (2025-02-01)